Cookies.

A line forms in Herald Square.

It is Wednesday. It is the middle of the afternoon. No one is here for a record release.

The line outside the Cookies SF flagship on 34th Street isn't long because anyone is selling cannabis inside. They aren't. New York's licensing labyrinth has made sure of that. The line is here for hoodies. Specifically, blue ones, with a script word in cursive that looks like it was scrawled in the margin of a notebook.

This is the trick that took Cookies from a Bay Area strain to a global brand. Sell the culture at the front door. Sell the cannabis where the law allows. Reverse the order most companies use, and an industry that was supposed to be commoditized into nothing becomes a luxury aisle instead.

It is fashionable, in cannabis-industry decks, to talk about brand. Cookies is the one company that has actually built one.

The most regulated industry that nobody could brand.

Legalization didn't fix marketing. It made marketing harder.

For decades, cannabis was sold in plastic bags by people who declined to leave business cards. Then it became legal, in a patchwork, state by state. You'd think the brands would arrive. They didn't, not really. Federal trademark protection? Unavailable for the plant itself. National advertising? Mostly blocked. Banking? Complicated. Distribution across state lines? Illegal.

So the industry produced a strange equilibrium - identical green crosses on identical strip-mall windows, run by either earnest hippies or earnest MBAs, none of whom had figured out how to make anyone outside their zip code remember the name.

This is the problem Berner and Jai saw in 2010. Their answer was almost insultingly simple, which is usually the sign of a good idea.

A rapper, a cultivator, and one strain.

Gilbert Anthony Milam Jr. - Berner to anyone who knows him - was eighteen when he started working at The Hemp Center in San Francisco. He met Jai Chang, known as Jigga, a few years later. Jigga had a strain.

They called it Girl Scout Cookies. (The actual Girl Scouts, predictably, sent a cease and desist. The name shortened to Cookies. The C&D arguably did the branding for them.) Within a year the strain was the most requested phenotype in Northern California dispensaries. Within five, it had spread across every legal market in the country, mostly unlicensed, mostly uncredited, and entirely unprofitable for the people who bred it.

Berner's bet was that you could fix that by treating cannabis the way Supreme treats t-shirts. Drop product. Limit supply. Sell to people who already wore the merch. Let the merch do the marketing for the cannabis nobody was allowed to advertise.

It sounded ridiculous in 2014. It sounds obvious now.

Genetics, in the legal sense.

A library of cultivars, not a catalog of SKUs.

Strip away the hoodies and the rappers and what Cookies actually sells is intellectual property. The genetics library now exceeds 150 proprietary cultivars - Gary Payton, Cereal Milk, the Lemonnade family, plus the original Cookies set - each one a phenotype that the company breeds, names, and licenses to state-level partners who handle local cultivation and retail.

This matters. It is the only honest competitive moat in cannabis. You cannot trademark a plant. You can be the only person on Earth who has the exact mother of a particular cross. Cookies has been quietly accumulating those mothers since 2010.

The numbers, where they're knowable.

Cookies is private. What follows is reported, not audited.

Cannabis is the rare industry where private companies stay private on purpose - public markets in this sector have not been kind. So the disclosure is patchier than you'd like. The shape, though, is clear enough.

Forbes pegged annual revenue at roughly $50 million in 2022, with a $250M valuation. The 2023 equity round closed at a higher valuation; the actual figure was not disclosed. By most reasonable estimates, the broader Berner-led empire - Cookies plus Lemonnade plus the accessories portfolio - clears materially more than the headline Cookies number alone.

Equity, in the cannabis sense.

A brand built on a strain associated with the war on drugs cannot pretend the war on drugs didn't happen.

This is the part where most cannabis companies write a paragraph about social impact and hope nobody reads it. Cookies has actually staked a position. Berner has been explicit about BIPOC ownership, equity licensing, and the rebuilding of communities that were prosecuted out of an industry they invented. The brand makes a point of partnering with operators in markets where the social equity license is itself the asset.

Skeptics will note that this is also good marketing. Both things can be true. The mission is structurally aligned with where cannabis is going - toward a legal market in which the underground operators get a path in, instead of being locked out by the well-capitalized newcomers who have spent the last five years writing checks and waiting for federal reform.

If federal legalization arrives, who's already there?

Cookies is.

The bet for the next decade is no longer whether legal cannabis becomes a real industry. It is which brands will own it when the dust settles. Most of the publicly traded multi-state operators are sitting on enormous debt loads and modest brand awareness. Many of the indie players never built distribution. Cookies has the rarer combination - a name people know, a genetics library nobody can copy, and a retail footprint already humming in six countries while the US waits on Congress.

There's a counter-narrative. Cookies has had financial turbulence - a 2024 court judgment briefly raised insolvency concerns, and the company has had to fight to control how its name appears in unauthorized stores. Operating in cannabis means operating in a place where the rule book is being written in real time. None of this is a stable industry yet. None of these companies are safe yet.

But step back to the line outside Herald Square. People are buying hoodies in a building where, by federal law, you cannot buy cannabis. That's the durable thing. That's what survives the next ten years of regulatory whiplash. The product is the brand. The brand is the product. The cannabis is almost a detail.

Or, to put it the way Berner does - they didn't build a cannabis brand. They built a culture. And the culture, for now, looks like a line of people in blue hoodies in 34th Street on a Wednesday afternoon. None of them seem to be going anywhere.